Landscapes / Companies
Suzhou Sanegene Bio Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 5 in all
Trials
4 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 29 Dec 2026Phase 2 trial completes | |||
| Next date | 29 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | IgA Nephropathy (IgAN), C3 Glomerulopathy and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Obesity & Overweight | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021